drugset
drugset / Trial / NCT05211011

Efficacy and Safety of Intravenous Fosfomycin in Prosthetic Joint Infection

NCT05211011 ↗

Phase 4 Unknown 226 enrolled Charite University, Berlin, Germany Pro-Implant Foundation · collab
NaSingle-groupOpen-labelTreatment

Summary

The PROOF Study is an open prospective interventional non-randomized study which aim is to determine the outcome / effect and safety of fosfomycin in patients with hip, knee or shoulder PJI.

Timeline

Start
2018-01-23
Primary completion
2022-04-30
Completion
2023-04-30

Drugs

EvaluationDrugModalityDoseRoute
Subject Fosfomycin Small molecule 5 g —

Indications

periprosthetic joint infection